FOXO4-DRI
PreclinicalThe peptide for clearing out 'zombie' cells — deep-research territory, huge longevity buzz.
What it is
FOXO4-DRI is a synthetic peptide adapted from a natural protein fragment. Its claim to fame is being a senolytic — a compound studied for clearing senescent cells, the aging cells that stop dividing but refuse to die. This is frontier research, not a wellness staple.
How it works
Aging cells survive by leaning on a 'tether' between two proteins, p53 and FOXO4. FOXO4-DRI is designed to cut that tether. Once broken, the aging cell's own safety switch flips and it clears itself — while healthy cells are largely left alone.
What people report
- ✦Focused on clearing senescent (zombie) cells that accumulate with age
- ✦Studied in animal models for signs of healthier aging and tissue function
- ✦The 'longevity' peptide people talk about most in the senolytics space
- ✦Still deep preclinical — no established human protocol
Typical use
In research it is typically run in short, pulsed cycles rather than continuously.
Dosing reference
No established human protocol exists. Any use is deep research territory — verify very carefully and do not assume a standard dose.
Reference only — not a recommendation. Verify via primary sources.
Watch for
This is among the least-studied peptides in this library. The senolytics field is exciting but young, and human evidence is essentially absent. Treat claims as plausible hypotheses, not tested benefits.
Notes
The longevity concept here is real and scientifically active — it just isn't proven in humans yet.
Reconstitution math for FOXO4-DRI
Typical vial: 2mg dissolved in 0.25ml BAC water. Adjust to see the math.
Reconstitution Calculator
Understand the math — pick a peptide, see its info, and how reconstitution works.
BPC-157
Healing & recoveryThe repair peptide everyone in the gym talks about — powerful in rats, still unproven in humans.
BPC-157 is a short chain of 15 amino acids. It is not a natural hormone your body makes on its own. It was built in a lab as a fragment of a larger 'body protection compound' first found in human stomach juice in the 1990s. Vendors sell this engineered piece, not a natural sequence.
How it works (optional detail)
In animal studies, BPC-157 seems to nudge faster blood-vessel growth at injured spots, which is the body's first step in healing. It also appears to quiet inflammation. The idea is that by tickling repair pathways rather than ordering one single thing, it helps tendons, ligaments, and gut lining recover speedier than they would on their own.
Dosing reference: Common community dosing is a few hundred micrograms a day, usually injected near the site or into belly fat. There is no approved human dose.
Reconstitution math
Concentration: 8.000 mg/ml (2mg in 0.25ml)
To get 1mg, draw:
0.125 ml
≈ 13 units on a U-100 insulin syringe
This calculator shows how the arithmetic works using common vial sizes. It is an educational illustration — not a dosing recommendation. Always follow the specific product's instructions and verify with primary sources or a qualified professional.
Educational content — not medical advice.